August 2, 2017
A team of engineers and pediatric orthopedic surgeons are using 3D printing to help train surgeons and shorten surgeries for the most common hip disorder found in children ages 9 to 16. In a recent study, researchers showed that allowing surgeons to prep on a 3D-printed model of the patient’s…
May 31, 2013
University of California, San Diego bioengineering professor Christian Metallo has been named a 2013 Searle Scholar. He will receive $300,000 over the next three years to pursue his research on the role of oxygen availability in dictating how fat is produced and metabolized in the body.
October 10, 2024
UC San Diego has received a $7 million ARPA-H contract for the PROTECT project, targeting pathogens like Pseudomonas aeruginosa and Staphylococcus aureus. These pathogens pose serious health risks to individuals with cystic fibrosis and those reliant on respirators.
April 2, 2020
…of data science and bioengineering at UC San Diego, leads the data analysis effort on the project. “Our first push is to get as many people involved as possible,” said Benjamin Smarr, who leads the data analysis effort and is a professor of data science and bioengineering at the Jacobs…
November 14, 2016
Biocom, the San Diego-based advocate for California’s life-science sector, has announced that the University of California San Diego has been named its “Community Partner of the Year” and will receive that recognition at the organization’s Annual Dinner on Nov. 17 at the La Jolla Hyatt Aventine.
December 9, 2020
What happens when different strains of bacteria are present in the same system? Do they co-exist? Do the strongest survive? In a microbial game of rock-paper-scissors, researchers at the University of California San Diego’s BioCircuits Institute uncovered a surprising answer.
August 21, 2013
MIT Technology Review has named Liangfang Zhang, a professor of nanoengineering at the University of California, San Diego, among the top 35 young innovators of 2013. For over a decade, the global media company has recognized a list of exceptionally talented technologists whose work has great potential to transform the…
September 11, 2019
Ventrix, a University of California San Diego spin-off company, has successfully conducted a first-in-human, FDA-approved Phase 1 clinical trial of an injectable hydrogel that aims to repair damage and restore cardiac function in heart failure patients who previously suffered a heart attack.
March 6, 2024
An injectable hydrogel can mitigate damage to the right ventricle of the heart with chronic pressure overload, according to a new study published March 6 in Journals of the American College of Cardiology: Basic to Translational Science.
January 30, 2014
Eight stem cell scientists at the University of California, San Diego have been awarded a total of $8.165 million to fund research tackling significant, unresolved issues in human stem cell biology.
